Coolsculpting With Cooltone Verses Coolsculpting Alone for the Banana Roll Area

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-14

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to evaluate the benefit and efficacy of CoolSculpting Elite study treatments versus CoolSculpting Elite study treatments followed by a series CoolTone for underneath the buttocks (also known as the banana roll).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultherapy for Buttock Lift

NCT02270892

Buttock Ptosis

COMPLETED NA

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

NCT06783621

Facial Contouring

ACTIVE_NOT_RECRUITING PHASE4

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

NCT01708460

Skin Laxity

COMPLETED NA

Safety and Effectiveness of Sculptra 011611 for Improvement in Appearance of Gluteal Skin Irregularities

NCT07324564

Gluteal Skin Irregularities

RECRUITING NA

VASER-Assisted Lipoplasty Compared With Suction-Assisted Lipoplasty

NCT00731354

Healthy

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigate safety and efficacy of CoolSculpting Elite treatments for underneath the buttocks (also known as the banana roll) versus sequential treatments of CoolSculpting Elite and CoolTone for the banana roll region.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Improved Appearance of the Banana Roll Region

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GROUP A=CoolSculpting Elite and CoolTone

Group A: Study subjects will have a total of 1 or 2 bilateral CoolSculpting Elite sessions to the banana roll area 6 weeks prior to four EMMS treatment sessions during the study.

Group Type EXPERIMENTAL

CoolSculpting Elite combined with CoolTone Treatments

Intervention Type DEVICE

Coolsculpting treatment combined with Cooltone treatments for the banana roll region of the buttocks.

GROUP B CoolSculpting Elite alone

Group B: Study subjects will have a total of 1 or 2 bilateral CoolSculpting Elite sessions to the banana roll area.

Group Type ACTIVE_COMPARATOR

CoolSculpting Elite

Intervention Type DEVICE

Coolsculpting treatment alone for the banana roll region of the buttocks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CoolSculpting Elite combined with CoolTone Treatments

Coolsculpting treatment combined with Cooltone treatments for the banana roll region of the buttocks.

Intervention Type DEVICE

CoolSculpting Elite

Coolsculpting treatment alone for the banana roll region of the buttocks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female ≥ 22 years and ≤65 years of age.
2. Subject has not had weight change exceeding 5% of body weight in the preceding month.
3. Subject agrees to maintain body weight within 5% during the study by not making any changes in diet or exercise routine.
4. Subject has a BMI ≤ 30 as determined at screening.
5. Subject agrees to have photographs taken of the treatment area(s) during the scheduled time periods.
6. Subject agrees to refrain from any new or change in gluteal muscle training exercises of the treatment area during the course of the study.
7. Subject agrees to avoid sun tanning or spray tanning during the course of the study. Subject has read and signed the study written informed consent form

Exclusion Criteria

1. Male Subjects
2. Subject has had a recent surgical procedure(s) in the area of intended treatment and muscle contractions may disrupt the healing process.
3. A subject with any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study.
4. A subject with a significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
5. Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) non-invasive fat reduction or skin tightening procedures , or cellulite treatment in the area of intended treatment
6. Subjects who tanned or spray tanned in the treatment area within the past 4 weeks
7. A subject with history of or the presence of any skin condition/disease in the treatment area that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) at the discretion of the investigator.
8. Subject needs to administer or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month
9. Subject hashad an intrauterine contraceptive device inserted or removed within the past month.
10. A subject with an active bacterial, fungal, or viral infection in the treatment area.
11. Subject has a bleeding disorder
12. Subject has a blood disorder such as cryoglobulinemia, cold agglutinin disease and paroxysmal cold hemoglobinuria.
13. Known sensitivity to cold such as cold urticaria, Raynaud's disease, pernio or Chilblains. Or patients with any impaired sensation in treated area
14. A subject with scarring or tattoos in the treatment area that might interfere with the diagnosis or study evaluations at the discretion of the investigator.
15. Subject is taking or has taken diet pills or supplements within the past month.
16. Subject has a metal implant or active implanted device such as a cardiac pacemaker, cochlear implant, intrathecal pump, hearing aids, defibrillator, or drug delivery system.
17. Subject has pulmonary insufficiency.
18. Subject has a cardiac disorder.
19. Subject has a malignant tumor.
20. Subject has been diagnosed with a seizure disorder such as epilepsy.
21. Subject currently has a fever.
22. Subject is diagnosed with Grave's disease.
23. Subject is pregnant or intending to become pregnant during the study period (in the next 9 months).
24. Subject is lactating or has been lactating in the past 6 months.
25. Subject is unable or unwilling to comply with the study requirements.
26. Subject is currently enrolled in a clinical study of any other investigational drug or device.
27. Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study.
28. Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject

Minimum Eligible Age

22 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes